NewAmsterdam Pharma appoints Robert Gunning as principal accounting officer

NewAmsterdam Pharma Co N.V.

Robert W. Gunning, 55, appointed principal accounting officer effective Aug 10, 2026, succeeding Louise Kooij (departs Aug 31, 2026).
Gunning joined as VP Controller; base salary $375,000/year, target bonus 30% of base, prorated for first year.
Equity grant: RSU covering 3,200 ordinary shares and option for 14,000 shares under 2024 Inducement Plan.
Prior roles: Interim Controller at Altimmune (Apr-Jul 2026), VP Finance/Controller at Y-mAbs (2022-2026), VP Controller at Excision Biotherapeutics (2021-2022).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.